PIK3CA signaling pathway alterations and the frequencies of PIK3CA mutations were varied in different types of non-small cell lung cancer (NSCLC) in different published studies4, 5, 6, 7. This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.